Metabolism Core
新陈代谢核心
基本信息
- 批准号:10747722
- 负责人:
- 金额:$ 27.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectBiological AssayCell CountCellsChronicChronic Kidney FailureCommunitiesConsultConsultationsDataDisease ProgressionDisease modelDoctor of MedicineDoctor of PhilosophyEducationElectron TransportEquipmentFacultyFunctional disorderGenesGenus HippocampusGlucoseHumanIn VitroInjuryInjury to KidneyIsotopesKidneyKidney DiseasesMeasuresMetabolicMetabolismMethodsMitochondriaObesityPalmitatesPathway interactionsPharmaceutical PreparationsPlayPre-Clinical ModelProcessProteinsProtocols documentationPyruvateRadioactiveReagentRecommendationRenal functionRenal tubule structureReproducibilityReproducibility of ResultsResearchResearch PersonnelResolutionResourcesRespirationRoleServicesSpirometryStandardizationTissuesTracerTrainingTubular formationUniversitiesUpdateValidationWashingtonWritingbiomedical resourcedesignfatty acid oxidationin vivoinstrumentationinterestliquid chromatography mass spectrometrylong chain fatty acidmetabolomicsnutritionoxidationprotein expressionresponsestable isotopetranscriptomics
项目摘要
Project Summary/Abstract: Metabolism Core
The Metabolism Core (Meta-Core) is a Biomedical Resource Core within the Washington University Chronic
Kidney Disease National Resource Center. Chronically injured kidneys have altered metabolism, and recent
data suggests that these metabolic changes play a causative role in progressive decline in kidney function.
The ability to interrogate metabolism is crucial to understanding chronic kidney disease pathophysiology, but
there are a number of barriers for kidney researchers to do so. First, many investigators interested in chronic
kidney disease do not have expertise in metabolism and metabolic assays. Second, many of these assays
require expensive equipment not readily available to many labs. To address these issues, the Meta-Core
faculty consisting of Leslie Gewin, M.D., Core Director, Brian Finck, Ph.D., Associate Core Director, Gary Patti,
Ph.D., Core Collaborator, and Leah Shriver, Ph.D., Core Collaborator, will perform consultations with Meta-
Core users to guide and design the best metabolic assay to answer the research question. Several assays will
be available to the Meta-Core users to interrogate metabolism at the cellular or whole kidney level. These
assays include Seahorse bioflux analyses with the use of primary cells or freshly isolated tubules ex vivo, both
more representative of the highly oxidative proximal tubules than commercially available primary human tubule
cells or conditionally immortalized tubule cells. We can measure oxidation of fatty acids or glucose/pyruvate in
kidney tissue ex vivo using radioactive substrate oxidation assays. The 3H-palmitate assay, not often
performed on kidney tissue, has advantages over the more commonly used 14C-palmitate assay as it detects
complete oxidation of long chain fatty acids through the electron transport chain and is easier to perform
(collect 3H2O rather than 14CO2). We can also refer users to the Nutrition Obesity Research Center’s high-
resolution respirometer (Oroboros Oxygraph 2k) to detect respiration in isolated mitochondria. In addition,
untargeted metabolomics and stable isotope tracer studies will be performed on primary cells in vitro and in
vivo. The Meta-Core faculty are all committed to sharing validated protocols and methods with the O’Brien
Consortium as well as larger scientific community. In addition, we will help train the kidney scientific community
how to generate primary proximal tubule cells and tubules and use the Seahorse bioflux analysis in a way that
yields consistent, reproducible results. In particular, the importance of validating cell number to use, post-
analysis correction for number of cells, and proper concentrations of reagents will be emphasized. The Meta-
Core will leverage the expertise and equipment of other Cores at Washington University to produce
complementary services for a reduced rate.
项目摘要/摘要:代谢核心
代谢核心(元核)是华盛顿大学慢性的生物医学资源核心
肾脏疾病国家资源中心。长期受伤的孩子改变了新陈代谢,最近
数据表明,这些代谢变化在肾脏功能的逐步下降中起着致病作用。
审问代谢的能力对于理解慢性肾脏病病理生理学至关重要,但是
肾脏研究人员有许多障碍。首先,许多对慢性感兴趣的调查员
肾脏疾病在代谢和代谢测定方面没有专业知识。其次,其中许多测定法
需要许多实验室不容易获得昂贵的设备。为了解决这些问题,元核
由M.D. Leslie Gewin的教师,Brian Finck博士核心主任,Gary Patti副总监,Gary Patti,
核心合作者和核心合作者Leah Shriver博士博士将与Meta-进行咨询
指导和设计最佳代谢测定法以回答研究问题的核心用户。会有几种测定
可以向元核用户使用在细胞或整个肾脏水平上询问代谢。这些
测定包括使用原代细胞或新鲜分离的管子的海马生物滤光管分析,均为体内
高度氧化近端管的代表性比市售的原代人体管更具代表性
细胞或有条件永生的小管细胞。我们可以测量脂肪酸或葡萄糖/丙酮酸的氧化
肾脏组织使用放射性底物氧化测定法。 3H-正确的测定法,不经常
在肾脏组织上进行的,比更常用的14c-贴木酸盐分析具有优势
通过电子传输链完全氧化长链脂肪酸,并且更容易执行
(收集3H2O而不是14CO2)。我们还可以将用户推荐给营养肥胖研究中心的高级
分辨率呼吸仪(Oroboros oxygraph 2k)检测分离的线粒体中的呼吸。此外,
未靶向的代谢组学和稳定的同位素示踪剂研究将在体外和在原代细胞上进行
体内。元核教师都致力于与O'Brien共享经过验证的协议和方法
财团以及更大的科学界。此外,我们将帮助培训肾脏科学界
如何生成原代近端管细胞和管子,并以一种方式使用Seahorse Bioflux分析
产生一致的,可再现的结果。特别是,验证使用单元格的重要性,
将强调细胞数量的分析校正和适当的试剂浓度。元 -
核心将利用华盛顿大学其他核心的专业知识和设备来生产
完全服务降低的速度。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Leslie S Gewin其他文献
Leslie S Gewin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Leslie S Gewin', 18)}}的其他基金
Epithelial Beta-catenin Signaling Improves Chronic Renal Injury
上皮β-连环蛋白信号传导改善慢性肾损伤
- 批准号:
10266013 - 财政年份:2018
- 资助金额:
$ 27.38万 - 项目类别:
Epithelial Beta-catenin Signaling Improves Chronic Renal Injury
上皮β-连环蛋白信号传导改善慢性肾损伤
- 批准号:
10612208 - 财政年份:2018
- 资助金额:
$ 27.38万 - 项目类别:
Cell Cycle and Metabolism in Chronically Injured Renal Tubules
慢性损伤肾小管的细胞周期和代谢
- 批准号:
10366536 - 财政年份:2016
- 资助金额:
$ 27.38万 - 项目类别:
Cell Cycle and Metabolism in Chronically Injured Renal Tubules
慢性损伤肾小管的细胞周期和代谢
- 批准号:
10661066 - 财政年份:2016
- 资助金额:
$ 27.38万 - 项目类别:
Cell Cycle and Metabolism in Chronically Injured Renal Tubules
慢性损伤肾小管的细胞周期和代谢
- 批准号:
10493373 - 财政年份:2016
- 资助金额:
$ 27.38万 - 项目类别:
TGF-beta Pathways that Protect Epithelia in Chronic Renal Injury
慢性肾损伤中保护上皮细胞的 TGF-β 通路
- 批准号:
9294119 - 财政年份:2016
- 资助金额:
$ 27.38万 - 项目类别:
TGF-beta Pathways that Protect Epithelia in Chronic Renal Injury
慢性肾损伤中保护上皮细胞的 TGF-β 通路
- 批准号:
9337599 - 财政年份:2016
- 资助金额:
$ 27.38万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 27.38万 - 项目类别:
The role and mechanism of RNA m6A modification in the pathogenesis and drug-resistance of prostate cancer
RNA m6A修饰在前列腺癌发病及耐药中的作用及机制
- 批准号:
10638634 - 财政年份:2023
- 资助金额:
$ 27.38万 - 项目类别:
A role for cardiomyocyte pannexin 1 in non-ischemic heart failure
心肌细胞pannexin 1在非缺血性心力衰竭中的作用
- 批准号:
10680109 - 财政年份:2023
- 资助金额:
$ 27.38万 - 项目类别:
The role of core circadian regulator Bmal1 in axonal regeneration and nerve repair
核心昼夜节律调节因子 Bmal1 在轴突再生和神经修复中的作用
- 批准号:
10677932 - 财政年份:2023
- 资助金额:
$ 27.38万 - 项目类别:
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
- 批准号:
10648346 - 财政年份:2023
- 资助金额:
$ 27.38万 - 项目类别: